Seroquel

Latest articles

13d
The Courier
Setting tone to curb prescription drug abusedrugs — including oxycodone, morphine and Ritalin — and some high-risk prescrip
The Courier / Posted 13 days ago
drugs — including oxycodone, morphine and Ritalin — and some high-risk prescription medications such a Stillnox, Valium and Seroquel. The training system is being developed under a consortium, led by WVPHN, and including all six Victorian primary... Read more
14d
Geelong Advertiser
New system targets silent killerclinics, 1300 pharmacies and 200 hospitals. The system will include monitoring
Geelong Advertiser / Posted 14 days ago
clinics, 1300 pharmacies and 200 hospitals. The system will include monitoring of all controlled drugs — including oxycodone, morphine, Ritalin and dexamphetamine — and some high-risk prescription medications such a Stillnox, Valium and Se... Read more
16d
Business Wire
Chi-Med Reports 2017 Interim Results and Updates Shareholders on Key Clinical Programs– our Prescription Drugs commercial services business – Continued commercial su
Business Wire / Posted 16 days ago
– our Prescription Drugs commercial services business – Continued commercial success in the first half of 2017 on Seroquel® (bi-polar disorder/schizophrenia), which grew sales by 10% to $18.9 million (H1 2016: 17.2m), and Concor®... Read more
16d
The Manteca Bulletin
Reader has reservations about sleep aidmedicine, Remeron, left me unable to shake the grogginess at daybreak. My docto
The Manteca Bulletin / Posted 16 days ago
medicine, Remeron, left me unable to shake the grogginess at daybreak. My doctor has since switched me to a low dose of Seroquel (25 mg per day) for sleep. I recently came across an article on social media that suggests that studies have... Read more
20d
5 Eyewitness News St. Paul
Shares in AstraZeneca dive as key cancer drug trial failsdeclined 10 percent to $5.05 billion as sales of the cholesterol drug Crestor f
5 Eyewitness News St. Paul / Posted 20 days ago
declined 10 percent to $5.05 billion as sales of the cholesterol drug Crestor fell 40 percent. Sales of the anti-depressant Seroquel XR dropped 58 percent. Net income totaled $477 million compared with a loss of $3 million in the same quarter last... Read more
20 related articles
20d
Connecticut Post
Shares in AstraZeneca dive as key cancer drug trial failsdeclined 10 percent to $5.05 billion as sales of the cholesterol drug Crestor f
Connecticut Post / Posted 20 days ago
declined 10 percent to $5.05 billion as sales of the cholesterol drug Crestor fell 40 percent. Sales of the anti-depressant Seroquel XR dropped 58 percent. Net income totaled $477 million compared with a loss of $3 million in the same quarter last... Read more
20 related articles
20d
Darien News-Review
Shares in AstraZeneca dive as key cancer drug trial failsdeclined 10 percent to $5.05 billion as sales of the cholesterol drug Crestor f
Darien News-Review / Posted 20 days ago
declined 10 percent to $5.05 billion as sales of the cholesterol drug Crestor fell 40 percent. Sales of the anti-depressant Seroquel XR dropped 58 percent. Net income totaled $477 million compared with a loss of $3 million in the same quarter last... Read more
20 related articles
20d
Stamford Advocate
Shares in AstraZeneca dive as key cancer drug trial failsdeclined 10 percent to $5.05 billion as sales of the cholesterol drug Crestor f
Stamford Advocate / Posted 20 days ago
declined 10 percent to $5.05 billion as sales of the cholesterol drug Crestor fell 40 percent. Sales of the anti-depressant Seroquel XR dropped 58 percent. Net income totaled $477 million compared with a loss of $3 million in the same quarter last... Read more
20 related articles
20d
Chattanooga Times Free Press
Shares in AstraZeneca dive as key cancer drug trial failsdeclined 10 percent to $5.05 billion as sales of the cholesterol drug Crestor f
Chattanooga Times Free Press / Posted 20 days ago
declined 10 percent to $5.05 billion as sales of the cholesterol drug Crestor fell 40 percent. Sales of the anti-depressant Seroquel XR dropped 58 percent. Net income totaled $477 million compared with a loss of $3 million in the same quarter last... Read more
20 related articles
20d
Daily Herald
AstraZeneca revenue down as key drugs lose patent protectionAnglo-Swedish drugmaker AstraZeneca says second-quarter revenue fell amid decli
Daily Herald / Posted 20 days ago
Anglo-Swedish drugmaker AstraZeneca says second-quarter revenue fell amid declining sales of blockbuster drugs Crestor and Seroquel XR, which lost patent protection in the United States last year. Total revenue declined 10 percent to $5.05 billion... Read more
4 related articles
20d
WFMZ Eastern Pennsylvania and Western New Jersey
AstraZeneca revenue down as key drugs lose patent protectionAnglo-Swedish drugmaker AstraZeneca says second-quarter revenue fell amid decli
WFMZ Eastern Pennsylvania and Western New Jersey / Posted 20 days ago
Anglo-Swedish drugmaker AstraZeneca says second-quarter revenue fell amid declining sales of blockbuster drugs Crestor and Seroquel XR, which lost patent protection in the United States last year. Total revenue declined 10 percent to $5.05 billion... Read more
4 related articles
20d
FOX Business
AstraZeneca revenue down as key drugs lose patent protectionAnglo-Swedish drugmaker AstraZeneca says second-quarter revenue fell amid decli
FOX Business / Posted 20 days ago
Anglo-Swedish drugmaker AstraZeneca says second-quarter revenue fell amid declining sales of blockbuster drugs Crestor and Seroquel XR, which lost patent protection in the United States last year. Total revenue declined 10 percent to $5.05 billion... Read more
4 related articles
20d
FOX Business
AstraZeneca revenue down as key drugs lose patent protectionAnglo-Swedish drugmaker AstraZeneca says second-quarter revenue fell amid decli
FOX Business / Posted 20 days ago
Anglo-Swedish drugmaker AstraZeneca says second-quarter revenue fell amid declining sales of blockbuster drugs Crestor and Seroquel XR, which lost patent protection in the United States last year. Continue Reading Below Total revenue declined 10... Read more
4 related articles
20d
WFTV 9 Orlando
AstraZeneca revenue down as key drugs lose patent protectionAnglo-Swedish drugmaker AstraZeneca says second-quarter revenue fell amid decli
WFTV 9 Orlando / Posted 20 days ago
Anglo-Swedish drugmaker AstraZeneca says second-quarter revenue fell amid declining sales of blockbuster drugs Crestor and Seroquel XR, which lost patent protection in the United States last year. Total revenue declined 10 percent to $5.05 billion... Read more
4 related articles

In this news